Ronald E Osman insider trades
Open-market stock purchases and sales by Ronald E Osman, Director, 10% Owner at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since Feb 24, 2009.
Recent trades
No open-market trades in the last 12 months.
Open-market stock purchases and sales by Ronald E Osman, Director, 10% Owner at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since Feb 24, 2009.
No open-market trades in the last 12 months.